Generic placeholder image

Current Nanomedicine

Editor-in-Chief

ISSN (Print): 2468-1873
ISSN (Online): 2468-1881

Review Article

Nanoencapsulation of Colchicum speciosum for Alleviating Lower Back Pain

Author(s): Siavash Beiranvand and Farshad Hassanzadeh Kiabi*

Volume 15, Issue 2, 2025

Published on: 03 May, 2024

Page: [173 - 179] Pages: 7

DOI: 10.2174/0124681873287041240328133414

Price: $65

Abstract

This review focuses on the use of Colchicum species that have been capsuled to treat lower back pain. Low levels of physical activity produce atypical spinal loading, which increases the risk of discomfort and damage. Acetylcholine (AChE inhibitors acetylcholinesterase AChE-I) has a crucial role in the development of amyloid- plaques, one of the disease's main pathogenic processes, and in boosting psychological function. To increase the natural preservatives in food, research on the encapsulation of phytochemicals has been employed to create nanoparticle delivery systems for a combination of terpenes that have been isolated from plants. For the administration of formulations containing encapsulated plant extracts, dermal and oral routes are used. The current strategies of encapsulation should be enhanced, as well as techniques to achieve the goal.

Keywords: Nanoencapsulation, back pain, colchicum, terpenes, plant extracts, dermal routes, oral routes.

Graphical Abstract
[1]
Intravenous colchicine for low-back pain: A double-blind study. Abstract : Europe PMC. Available from: https://europepmc.org/article/med/2145645 [cited 2023 Jun 9].
[2]
Sapra S, Bhalla Y, Nandani , et al. Colchicine and its various physicochemical and biological aspects. Med Chem Res 2013; 22(2): 531-47.
[http://dx.doi.org/10.1007/s00044-012-0077-z]
[3]
Düşen OD, Sümbül H. A morphological investigation of Colchicum L. (Liliaceae) species in the Mediterranean region in Turkey. Turk J Bot 2007; 31(5): 373-419.
[4]
Chrubasik C, Wiesner L, Black A, Müller-Ladner U, Chrubasik S. A one-year survey on the use of a powder from Rosa canina lito in acute exacerbations of chronic pain. Phytother Res 2008; 22(9): 1141-8.
[http://dx.doi.org/10.1002/ptr.2352] [PMID: 18729248]
[5]
Fan C, Pacier C, Martirosyan DM, Martirosyan D. Rose hip Rosa canina L): A functional food perspective. Funct Foods Health Dis 2014; 4(4)
[6]
PH D Flora of Turkey and the East Aegean Islands. Edinb Univ Press 1965; 3: pp. 1-628.
[7]
Al-Mahmoud MS, Alali FQ, Tawaha K, Qasaymeh RM. Phytochemical study and cytotoxicity evaluation of Colchicum stevenii Kunth (Colchicaceae): A Jordanian meadow saffron. Nat Prod Res 2006; 20(2): 153-60.
[http://dx.doi.org/10.1080/14786410500046224] [PMID: 16319009]
[8]
Larsen E, Kharazmi A, Christensen LP, Christensen SB. An antiinflammatory galactolipid from rose hip Rosa canina) that inhibits chemotaxis of human peripheral blood neutrophils in vitro. J Nat Prod 2003; 66(7): 994-5.
[http://dx.doi.org/10.1021/np0300636] [PMID: 12880322]
[9]
Lattanzio F, Greco E, Carretta D, Cervellati R, Govoni P, Speroni E. In vivo anti-inflammatory effect of Rosa canina L.extract. J Ethnopharmacol 2011; 137(1): 880-5.
[http://dx.doi.org/10.1016/j.jep.2011.07.006] [PMID: 21771653]
[10]
Alizadeh R, Taheri M, Beiranvand S, Fereydoonnia B. Evaluation of the effectiveness of botulinum toxin injection on reducing phantom pain in patients. Interdiscip Neurosurg 2023; 32: 101712.
[http://dx.doi.org/10.1016/j.inat.2022.101712]
[11]
Adams MA. Biomechanics of back pain. Acupunct Med 2004; 22(4): 178-88.
[http://dx.doi.org/10.1136/aim.22.4.178] [PMID: 15628775]
[12]
Hoy D, Brooks P, Blyth F, Buchbinder R. The Epidemiology of low back pain. Best Pract Res Clin Rheumatol 2010; 24(6): 769-81.
[http://dx.doi.org/10.1016/j.berh.2010.10.002] [PMID: 21665125]
[13]
Goetzel RZ, D’Arco M, Thomas J, et al. Measuring the prevalence and incidence of low back pain disorders among american workers in the aerospace and defense industry. J Occup Environ Med 2015; 57(9): 998-1003.
[http://dx.doi.org/10.1097/JOM.0000000000000512] [PMID: 26340288]
[14]
Calvo-Muñoz I, Gómez-Conesa A, Sánchez-Meca J. Prevalence of low back pain in children and adolescents: A meta-analysis. BMC Pediatr 2013; 13(1): 14.
[http://dx.doi.org/10.1186/1471-2431-13-14] [PMID: 23351394]
[15]
Allen R. Chronic low back pain: evaluation and management. Am Fam Physician 2009; 79(12): 1067-74.
[16]
Ehrlich GE. Low back pain. Bull World Heal Org 2003; 1-12.
[17]
Nachemson A, Jonsson E. Neck and back pain : the scientific evidence of causes, diagnosis, and treatment. Lippincott Williams & Wilkins 2000; pp. 1-495.
[18]
Deyo RA, Mirza SK, Martin BI. Back pain prevalence and visit rates: Estimates from U.S. national surveys, 2002. Spine 2006; 31(23): 2724-7.
[http://dx.doi.org/10.1097/01.brs.0000244618.06877.cd] [PMID: 17077742]
[19]
Musculoskeletal disorders and the workplace: Low back and upper extremities-executive summary. Theor Issues Ergon Sci 2001.
[20]
Palmer KT, Griffin MJ, Syddall HE, Pannett B, Cooper C, Coggon D. The relative importance of whole body vibration and occupational lifting as risk factors for low-back pain. Occup Environ Med 2003; 60(10): 715-21.
[http://dx.doi.org/10.1136/oem.60.10.715] [PMID: 14504358]
[21]
Sterud T, Johannessen HA, Tynes T. Work-related psychosocial and mechanical risk factors for neck/shoulder pain: A 3-year follow-up study of the general working population in Norway. Int Arch Occup Environ Health 2014; 87(5): 471-81.
[http://dx.doi.org/10.1007/s00420-013-0886-5] [PMID: 23708752]
[22]
Walsh K, Varnes N, Osmond C, Styles R, Coggon D. Occupational causes of low-back pain. Scand J Work Environ Health 1989; 15(1): 54-9.
[http://dx.doi.org/10.5271/sjweh.1891] [PMID: 2522238]
[23]
Bakker EWP, Verhagen AP, van Trijffel E, Lucas C, Koes BW. Spinal mechanical load as a risk factor for low back pain: A systematic review of prospective cohort studies. Spine 2009; 34(8): E281-93.
[http://dx.doi.org/10.1097/BRS.0b013e318195b257] [PMID: 19365237]
[24]
McLean D, Pearce N, Walls CB, Wigley RD. The “Twin Study” and the misunderstanding of epidemiology that clouds occupational associations and low back disorder. N Z Med J 2011; 124(1339): 109-11.
[PMID: 21952340]
[25]
Lambeek LC, van Tulder MW, Swinkels ICS, Koppes LLJ, Anema JR, van Mechelen W. The trend in total cost of back pain in The Netherlands in the period 2002 to 2007. Spine 2011; 36(13): 1050-8.
[http://dx.doi.org/10.1097/BRS.0b013e3181e70488] [PMID: 21150697]
[26]
Perez-Cruet M. Minimally invasive spine surgery: Advances and Innovations. intechopen 2022; pp. 1-186.
[http://dx.doi.org/10.5772/intechopen.93743]
[27]
Luo X, Pietrobon R, X Sun S, Liu GG, Hey L. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine 2004; 29(1): 79-86.
[http://dx.doi.org/10.1097/01.BRS.0000105527.13866.0F] [PMID: 14699281]
[28]
Full article: Pain management using nanotechnology approaches. Available from: https://www.tandfonline.com/doi/full/10.1080/ 21691401.2018.1553885 [cited 2023 May 29].
[29]
Das A, Shanker G, Nath C, Pal R, Singh S, Singh HK. A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba. Pharmacol Biochem Behav 2002; 73(4): 893-900.
[http://dx.doi.org/10.1016/S0091-3057(02)00940-1] [PMID: 12213536]
[30]
Prince M, Wimo A, Guerchat M, Ali GC, Wu YT, Prina M. World Alzheimer Report 2015. Alzheimer’s Disease International- World Alzheimer Report 2015.
[31]
Beiranvand S, Moradkhani M. Bupivacaine versus liposomal bupivacaine for pain control. Drug Res 2018; 68(7): 365-9.
[http://dx.doi.org/10.1055/s-0043-121142] [PMID: 29108087]
[32]
Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989; 55(1): R1-4.
[http://dx.doi.org/10.1016/0378-5173(89)90281-0]
[33]
Sanson C, Schatz C, Le Meins JF, et al. A simple method to achieve high doxorubicin loading in biodegradable polymersomes. J Control Release 2010; 147(3): 428-35.
[http://dx.doi.org/10.1016/j.jconrel.2010.07.123] [PMID: 20692308]
[34]
Barwal I, Sood A, Sharma M, Singh B, Yadav SC. Development of stevioside Pluronic-F-68 copolymer based PLA-nanoparticles as an antidiabetic nanomedicine. Colloids Surf B Biointerfaces 2013; 101: 510-6.
[http://dx.doi.org/10.1016/j.colsurfb.2012.07.005] [PMID: 23022553]
[35]
Eidi H, Joubert O, Némos C, et al. Drug delivery by polymeric nanoparticles induces autophagy in macrophages. Int J Pharm 2012; 422(1-2): 495-503.
[http://dx.doi.org/10.1016/j.ijpharm.2011.11.020] [PMID: 22119964]
[36]
Cheow WS, Hadinoto K. Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: Modifications of standard nanoparticle preparation methods. Colloids Surf Physicochem Eng Asp 2010; 370(1-3): 79-86.
[37]
Bilensoy E, Sarisozen C, Esendağlı G, et al. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors. Int J Pharm 2009; 371(1-2): 170-6.
[http://dx.doi.org/10.1016/j.ijpharm.2008.12.015] [PMID: 19135514]
[38]
Lassalle V, Ferreira ML. PLA nano- and microparticles for drug delivery: An overview of the methods of preparation. Macromol Biosci 2007; 7(6): 767-83.
[http://dx.doi.org/10.1002/mabi.200700022] [PMID: 17541922]
[39]
Khayata N, Abdelwahed W, Chehna MF, Charcosset C, Fessi H. Stability study and lyophilization of vitamin E-loaded nanocapsules prepared by membrane contactor. Int J Pharm 2012; 439(1-2): 254-9.
[http://dx.doi.org/10.1016/j.ijpharm.2012.09.032] [PMID: 23010283]
[40]
Full article: Antinociceptive synergistic interaction between Achillea millefolium and Origanum vulgare L. extract encapsulated in liposome in rat.Available from: https://www.tandfonline.com/doi/full/10.1080/21691401.2017.1354303 [cited 2023 May 29].
[41]
Hasanzadeh-Kiabi F. Nano-drug for Pain Medicine. Drug Res 2018; 68(5): 245-9.
[http://dx.doi.org/10.1055/s-0043-120661] [PMID: 29100265]
[42]
Gaysinsky S, Taylor TM, Davidson PM, Bruce BD, Weiss J. Antimicrobial efficacy of eugenol microemulsions in milk against Listeria monocytogenes and Escherichia coli O157:H7. J Food Prot 2007; 70(11): 2631-7.
[http://dx.doi.org/10.4315/0362-028X-70.11.2631] [PMID: 18044447]
[43]
Applications of drug anesthesia in control chronic pain: Journal of Investigative Surgery: Vol 32, No 3. Available from: https://www.tandfonline.com/doi/abs/10.1080/08941939.2017.1397230 [cited 2023 Jun 9].
[44]
Lacaille-Dubois MA, Mitaine-Offer AC. Triterpene saponins from Polygalaceae. Phytochem Rev 4 2005; 139-49.
[http://dx.doi.org/10.1007/s11101-005-2606-6]
[45]
Kindscher K. Medicinal wild plants of the prairie an ethnobotanical guide. Univ Pr of Kansas 1992; pp. 1-336.
[46]
Kako M, Miura T, Nishiyama Y, Ichimaru M, Moriyasu M, Kato A. Hypoglycemic effect of the rhizomes of Polygala senega in normal and diabetic mice and its main component, the triterpenoid glycoside senegin-II. Planta Med 1996; 62(5): 440-3.
[http://dx.doi.org/10.1055/s-2006-957935] [PMID: 8923811]
[47]
Katselis GS, Estrada A, Gorecki DKJ, Barl B. Adjuvant activities of saponins from the root of Polygala senega L. This article is one of a selection of papers published in this special issue (part 2 of 2) on the Safety and Efficacy of Natural Health Products. Can J Physiol Pharmacol 2007; 85(11): 1184-94.
[http://dx.doi.org/10.1139/Y07-109] [PMID: 18066120]
[48]
Salvioli S, Sikora E, Cooper EL, Franceschi C. Curcumin in cell death processes: A challenge for CAM of age-related pathologies. Evid Based Complement Alternat Med 2007; 4(2): 181-90.
[http://dx.doi.org/10.1093/ecam/nem043] [PMID: 17549234]
[49]
Lee HS, Ahn YJ. Growth-Inhibiting Effects of Cinnamomum cassia bark-derived materials on human intestinal bacteria. J Agric Food Chem 1998; 46(1): 8-12.
[http://dx.doi.org/10.1021/jf970548y] [PMID: 10554188]
[50]
Amendola D, De Faveri DM, Spigno G. Grape marc phenolics: Extraction kinetics, quality and stability of extracts. J Food Eng 2010; 97(3): 384-92.
[http://dx.doi.org/10.1016/j.jfoodeng.2009.10.033]
[51]
Schmeda-Hirschmann G, Yesilada E. Traditional medicine and gastroprotective crude drugs. J Ethnopharmacol 2005; 100(1-2): 61-6.
[http://dx.doi.org/10.1016/j.jep.2005.06.002] [PMID: 15993015]
[52]
Flanagan J, Singh H. Microemulsions: A potential delivery system for bioactives in food. Crit Rev Food Sci Nutr 2006; 46(3): 221-37.
[http://dx.doi.org/10.1080/10408690590956710] [PMID: 16527754]
[53]
Vanderhoff JW, Ugelstad J, Mohamed SEA. Polymer emulsification process. Patent. US4177177A, 1979.
[54]
Zafar N, Fessi H, Elaissari A. Cyclodextrin containing biodegradable particles: From preparation to drug delivery applications. Int J Pharm 2014; 461(1-2): 351-66.
[http://dx.doi.org/10.1016/j.ijpharm.2013.12.004] [PMID: 24342710]
[55]
Giri TK, Choudhary C, Ajazuddin , Alexander A, Badwaik H, Tripathi DK. Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery. Saudi Pharm J 2013; 21(2): 125-41.
[http://dx.doi.org/10.1016/j.jsps.2012.05.009]
[56]
Crotts G, Park TG. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issues. J Microencapsul 1998; 15(6): 699-713.
[http://dx.doi.org/10.3109/02652049809008253] [PMID: 9818948]
[57]
Okochi H, Nakano M. Preparation and evaluation of w/o/w type emulsions containing vancomycin. Adv Drug Deliv Rev 2000; 45(1): 5-26.
[http://dx.doi.org/10.1016/S0169-409X(00)00097-1] [PMID: 11104894]
[58]
Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release Off J Control Release Soc 2003; 90(3): 261-80.
[http://dx.doi.org/10.1016/S0168-3659(03)00194-9]
[59]
Khoee S, Yaghoobian M. An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion. Eur J Med Chem 2009; 44(6): 2392-9.
[http://dx.doi.org/10.1016/j.ejmech.2008.09.045] [PMID: 19010570]
[60]
Tammam S, Mathur S, Afifi N. Preparation and biopharmaceutical evaluation of tacrolimus loaded biodegradable nanoparticles for liver targeting. J Biomed Nanotechnol 2012; 8(3): 439-49.
[http://dx.doi.org/10.1166/jbn.2012.1403] [PMID: 22764413]
[61]
Barratt G. Colloidal drug carriers: Achievements and perspectives. Cell Mol Life Sci 2003; 60(1): 21-37.
[http://dx.doi.org/10.1007/s000180300002] [PMID: 12613656]
[62]
Schultz S, Wagner G, Urban K, Ulrich J. High-pressure homogenization as a process for emulsion formation. Chem Eng Technol 2004; 27(4): 361-8.
[http://dx.doi.org/10.1002/ceat.200406111]
[63]
Das J, Das S, Samadder A, Bhadra K, Khuda-Bukhsh AR. Poly (lactide-co-glycolide) encapsulated extract of Phytolacca decandra demonstrates better intervention against induced lung adenocarcinoma in mice and on A549 cells. Eur J Pharm Sci 2012; 47(2): 313-24.
[http://dx.doi.org/10.1016/j.ejps.2012.06.018] [PMID: 22771545]
[64]
Jia D, Barwal I, Thakur S, Yadav SC. Methodology to nanoencapsulate hepatoprotective components from Picrorhiza kurroa as food supplement. Food Biosci 2015; 9: 28-35.
[http://dx.doi.org/10.1016/j.fbio.2014.10.005]
[65]
Bhattacharyya SS, Paul S, Khuda-Bukhsh AR. Encapsulated plant extract ( Gelsemium sempervirens ) poly (lactide-co-glycolide) nanoparticles enhance cellular uptake and increase bioactivity in vitro. Exp Biol Med 2010; 235(6): 678-88.
[http://dx.doi.org/10.1258/ebm.2010.009338] [PMID: 20511672]
[66]
Narayanan S, Binulal NS, Mony U, Manzoor K, Nair S, Menon D. Folate targeted polymeric ‘green’ nanotherapy for cancer. Nanotechnology 2010; 21(28): 285107.
[http://dx.doi.org/10.1088/0957-4484/21/28/285107] [PMID: 20585151]
[67]
Samadder A, Das S, Das J, Paul A, Khuda-Bukhsh AR. Ameliorative effects of Syzygium jambolanum extract and its poly (lactic- co-glycolic) acid nano-encapsulated form on arsenic-induced hyperglycemic stress: A multi-parametric evaluation. JAMS J Acupunct Meridian Stud 2012; 5(6): 310-8.
[http://dx.doi.org/10.1016/j.jams.2012.09.001]
[68]
Strasser M, Noriega P, Löbenberg R, Bou-Chacra N, Bacchi EM. Antiulcerogenic potential activity of free and nanoencapsulated passiflora serratodigitata L. extracts. BioMed Res Int 2014; 2014: 434067.
[69]
Tachaprutinun A, Meinke MC, Richter H, et al. Comparison of the skin penetration of Garcinia mangostana extract in particulate and non-particulate form. Eur J Pharm Biopharm 2014; 86(2): 307-13.
[http://dx.doi.org/10.1016/j.ejpb.2013.12.001] [PMID: 24321393]
[70]
Pan-In P, Wanichwecharungruang S, Hanes J, Kim AJ. Cellular trafficking and anticancer activity of Garcinia mangostana extract-encapsulated polymeric nanoparticles. Int J Nanomedicine 2014; 9: 3677-86.
[PMID: 25125977]
[71]
Paul S, Bhattacharyya SS, Boujedaini N, et al. Anticancer potentials of root extract of polygala senega and its plga nanoparticles-encapsulated form, anticancer potentials of root extract of polygala senega and its PLGA nanoparticles-encapsulated form. Evid-Based Complement Altern Med Evid-Based Complement Altern Med 2010; 2010: 517204.

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy